MarkRobertHofmeyerMDFACC

Heart Failure & Transplantation, Cardiovascular Disease Genetics

Associate Professor of Medicine - Georgetown University

Overview of Dr. Hofmeyer

I am a board certified cardiologist specializing in the management of advanced heart failure, including mechanical circulatory support and heart transplantation.

Office
110 Irving St NW
A132
Washington, DC 20010
Book by Phone+1(608) 420-6627

Education & Training

University of Miami/Jackson Health SystemFellowship, Advanced Heart Failure and Transplant Cardiology, 2010 - 2011
University of Miami/Jackson Health SystemFellowship, Cardiovascular Disease, 2007 - 2010
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2004 - 2007
Wayne State University School of MedicineClass of 2004
Wayne State University School of MedicineMS, Medical Sciences , 1998 - 2000
University of MichiganBS, Biology, 1989 - 1993

Certifications & Licensure

MD State Medical License 2021 - 2026
VA State Medical License 2022 - 2026
DC State Medical License 2011 - 2024
FL State Medical License 2008 - 2012
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACC) American College of Cardiology

Clinical Trials

DCM Precision Medicine Study Start of enrollment: 2016 Jun 07
Active, not recruiting
Not Applicable
Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis Start of enrollment: 2022 Jun 22
Recruiting
Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Giant Cell Myocarditis vs Cardiac Sarcoidosis: Reconsidering the Diagnosis With FDG PET Imaging.
Ethan J Fraser, Austin Culver, Phillip H Lam, Mark Hofmeyer, Farooq H Sheikh
JACC. Case Reports. 2024-11-20
Surveillance Imaging and Management of Cardiac Sarcoidosis After Advanced Heart Failure Therapies.
Richa Gupta, Francisca Bermudez, Tania Vora, Navid Homayouni, Gaby Weissman
The American Journal of Cardiology. 2024-07-01
1 citations
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic-Related Dilated Cardiomyopathy.
Pablo Garcia-Pavia, Jose Fernando Rodriguez Palomares, Gianfranco Sinagra, Roberto Barriales-Villa, Neal K Lakdawala
Circulation. Heart Failure. 2024-07-01

Press Mentions

DCM Precision Medicine StudyJanuary 31st, 2017
Study Shows Benefit of Routine Genetic Testing of Dilated Cardiomyopathy Patients with Advanced Heart DiseaseAugust 30th, 2023
Multi-Center Study Finds Routine Genetic Testing Could Benefit Patients with Advanced Inherited Heart Muscle DiseaseAugust 31st, 2023

Professional Memberships

American College of Cardiology - ACC
Fellow
International Society of Heart and Lung Transplant
Member
Heart Failure Society of America
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
Blue Shield California HMO
Blue Shield California PPO
CareFirst BCBS Maryland POS
CareFirst BlueChoice Advantage
CareFirst BlueChoice Network POS
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment